XML 52 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Loss from Continuing Operations Before Provision for Income Tax

Loss from continuing operations before provision for income tax for the Company’s domestic and international operations was as follows (in thousands):

 

 

 

December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

US

 

$

(84,207

)

 

$

(113,679

)

 

$

129,361

 

Foreign

 

 

(2,528

)

 

 

(3,603

)

 

 

(3,697

)

Loss before provision for income taxes

 

$

(86,735

)

 

$

(117,282

)

 

$

125,664

 

Provision for Income Taxes The provision for income taxes consists of the following (in thousands):

 

 

Year Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Current

 

 

 

 

 

 

 

 

 

 

 

 

U.S. federal

 

$

 

 

$

 

 

$

 

U.S. state

 

 

 

 

 

 

 

 

 

Non-U.S.

 

 

240

 

 

 

51

 

 

 

 

Total current

 

 

240

 

 

 

51

 

 

 

 

Deferred

 

 

 

 

 

 

 

 

 

 

 

 

U.S. federal

 

 

(9,164

)

 

 

244,801

 

 

 

(43,814

)

U.S. state

 

 

(1,903

)

 

 

15,398

 

 

 

(4,311

)

Non-U.S.

 

 

 

 

 

 

 

 

 

Total deferred

 

 

(11,067

)

 

 

260,199

 

 

 

(48,125

)

Valuation allowance

 

 

11,067

 

 

 

(260,199

)

 

 

48,125

 

Total

 

$

240

 

 

$

51

 

 

$

 

 

Components of Net Deferred Tax Assets Components of the net deferred tax assets as of December 31, 2018 and 2017, are as follows (in thousands):

 

 

December 31,

 

 

 

2018

 

 

2017

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

524,377

 

 

$

507,235

 

Research and development credits

 

 

81,583

 

 

 

83,461

 

Capitalized research

 

 

557

 

 

 

1,016

 

Milestone Rights

 

 

3,521

 

 

 

1,908

 

Accrued expenses

 

 

1,156

 

 

 

211

 

Loss on purchase commitment

 

 

23,194

 

 

 

23,654

 

Non-qualified stock option expense

 

 

2,551

 

 

 

7,004

 

Capitalized patent costs

 

 

5,090

 

 

 

5,194

 

Other

 

 

669

 

 

 

795

 

Depreciation

 

 

22,560

 

 

 

23,820

 

Deferred Product Revenue & Costs

 

 

107

 

 

 

 

 

Total net deferred tax assets

 

 

665,365

 

 

 

654,298

 

Valuation allowance

 

 

(665,365

)

 

 

(654,298

)

Net deferred tax assets

 

$

 

 

$

 

 

Effective Income Tax Rate

The Company’s effective income tax rate differs from the statutory federal income tax rate as follows for the years ended December 31, 2018, 2017 and 2016:

 

 

 

December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Federal tax benefit rate

 

 

21.0

%

 

 

35.0

%

 

 

35.0

%

Permanent items

 

 

1.0

 

 

 

6.2

 

 

 

(1.9

)

Intercompany transfer of intellectual property

 

 

 

 

 

 

 

 

0.9

 

Tax law changes

 

 

(0.7

)

 

 

(265

)

 

 

 

Stock based compensation

 

 

(6.5

)

 

 

(5.0

)

 

 

 

Tax attribute expirations

 

 

(1.6

)

 

 

(2.8

)

 

 

 

Foreign withholding tax

 

 

(0.3

)

 

 

 

 

 

 

Valuation allowance

 

 

(13.2

)

 

 

231.6

 

 

 

(34.0

)

Effective income tax rate

 

 

-0.3

%

 

 

%

 

 

%